.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 7,307,166

« Back to Dashboard

Details for Patent: 7,307,166

Title:Oxpurine nucleosides and their congeners, and acyl, derivatives thereof, for improvement of hematopoiesis
Abstract: The invention relates to certain oxypurine nucleosides, congeners of such oxypurine nucleosides, and acyl derivatives thereof, and compositions which contain at least one of these compounds. The invention also relates to methods of treating or preventing hematopoietic disorders and modifying hematopoiesis, and treating or preventing inflammatory diseases and bacterial infections by administering a compound or composition of the present invention to an animal.
Inventor(s): von Borstel; Reid W. (Potomac, MD), Bamat; Michael K. (Potomac, MD), Hiltbrand; Bradley M. (Columbia, MD), Butler; James C. (Gaithersburg, MD), Shirali; Shyam (Gaithersburg, MD)
Assignee: Wellstat Therapeutics Corporation (Gaithersburg, MD)
Filing Date:Jun 05, 1995
Application Number:08/463,771
Claims:1. A compound having the formula: ##STR00029## wherein R.sub.A, R.sub.B and R.sub.D are the same, or different, and are hydrogen or I. an acyl group derived from a. an unbranched fatty acid with 6 to 22 carbon atoms, optionally substituted at the terminal carbon with a hydrophilic moiety selected from the group consisting of NH.sub.2, OH, OPO.sub.3.sup.=, PO.sub.3.sup.=, OSO.sub.3.sup.-, and SO.sub.3.sup.-, b. an amino acid selected from the group consisting of glycine, the L forms of phenylalanine, alanine, valine, leucine, isoleucine, tyrosine, proline, hydroxyproline, serine, threonine, cysteine, aspartic acid, glutamic acid, arginine, lysine, histidine and ornithine, c. an unbranched alkylene dicarboxylic acid having 3-22 carbon atoms, d. nicotinic acid, e. a cycloalkyl carboxylic acid containing 4 to 22 carbon atoms, f. a carboxylic acid derived from i. a polymer of ethylene glycol with the structure HOOC--(CH.sub.2).sub.m--(CH.sub.2CH.sub.2O).sub.nH or HOOC--(CH.sub.2).sub.m--(CH.sub.2CH.sub.2O).sub.nCH.sub.3, or ii. a polymer of vinyl alcohol with the structure HOOC--(CH.sub.2).sub.m--(CH.sub.2CHOH).sub.nH or HOOC--(CH.sub.2).sub.m--(CH.sub.2CHOH).sub.nCH.sub.3, where m=0-3 and n=2-8, or II. an unbranched alkyl radical with 3 to 22 carbon atoms, optionally substituted at the terminal carbon with a hydrophilic moiety selected from the group consisting of NH.sub.2, OH, OPO.sub.3.sup.=, PO.sub.3.sup.=, OSO.sub.3.sup.-, SO.sub.3.sup.-, provided that not all of the R.sub.A, R.sub.B, and R.sub.D are hydrogen, and Q=a halogen, NHR.sub.F, where R.sub.F is H or an alkyl radical or an acyl radical of a carboxylic acid, said radicals each containing 1 to 10 carbon atoms, SR.sub.G where R.sub.G is H or an alkyl radical or an acyl radical of a carboxylic acid, said radicals each containing 1 to 10 carbon atoms, or OR.sub.H where R.sub.H is H or an alkyl radical or an acyl radical of a carboxylic acid, said radicals each containing 1 to 10 carbon atoms, and Z is H, OH, or NHR.sub.C where R.sub.C.dbd.H or an acyl radical of a carboxylic acid with 2 to 30 carbon atoms or an alkyl radical with 2 to 30 carbon atoms; or a pharmaceutically acceptable salt thereof.

2. A compound having the formula: ##STR00030## wherein R.sub.1 is an acyl group derived from i. an unbranched fatty acid with 6 to 22 carbon atoms, optionally substituted at the terminal carbon with a hydrophilic moiety selected from the group consisting of NH.sub.2, OH, OPO.sub.3.sup.=, PO.sub.3.sup.=, OSO.sub.3.sup.-, SO.sub.3.sup.-, ii. an amino acid selected from the group consisting of glycine, the L form of phenylalanine, alanine, valine, leucine, isoleucine, tyrosine, proline, hydroxyproline, serine, threonine, cysteine, aspartic acid, glutamic acid, arginine lysine, histidine and ornithine, iii. a cycloalkyl carboxylic acid containing 4 to 22 carbon atoms, iv. a nicotinic acid, v. an aromatic carboxylic acid with 7 to 22 carbon atoms, or vi. a carboxylic acid derived from 1. a polymer of ethylene glycol with the structure HOOC--(CH.sub.2).sub.m--(CH.sub.2CH.sub.2O).sub.nH or HOOC--(CH.sub.2).sub.m--(CH.sub.2CH.sub.2O).sub.nCH.sub.3, or 2. a polymer of vinyl alcohol with the structure HOOC--(CH.sub.2).sub.m--(CH.sub.2CHOH).sub.nH or HOOC--(CH.sub.2).sub.m--(CH.sub.2CHOH).sub.nCH.sub.3, where m=0-3 and n=2-8, or R.sub.C is an unbranched alkyl radical with 3 to 22 carbon atoms, optionally substituted at the terminal carbon with a hydrophilic moiety selected from the group consisting of NH.sub.2, OH, PO.sub.3.sup.=, PO.sub.3.sup.=, OSO.sub.3.sup.-, SO.sub.3.sup.-, and Q=a halogen, NHR.sub.F, where R.sub.F is H or an alkyl radical or an acyl radical of a carboxylic acid, said radicals each containing 1 to 10 carbon atoms, SR.sub.G where R.sub.G is H or an alkyl radical or an acyl radical of a carboxylic acid, said radicals each containing 1 to 10 carbon atoms, or OR.sub.H where R.sub.H is H or an alkyl radical or an acyl radical of a carboxylic acid, said radicals each containing 1 to 10 carbon atoms; or a pharmaceutically acceptable salt thereof.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc